Abstract
CYP4F2 acts primarily as an enzyme that converts arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE), a metabolite involved in the regulation of blood pressure in humans. The aim of the present study was to assess the association between the human CYP4F2 gene and essential hypertension (EH) using a haplotype-based case-control study that included separate analysis of the two gender groups. The 249 EH patients and 238 age-matched controls were genotyped for 5 single-nucleotide polymorphisms (SNPs) of the human CYP4F2 gene (rs3093105, rs3093135, rs1558139, rs2108622, rs3093200). Data were analyzed for 3 separate groups: all subjects, and men and women separately. For the total population and for male subjects, the distribution of the dominant model of rs1558139 (CC vs. CT+TT) differed significantly between the EH patients and control subjects (p=0.037 and p=0.005, respectively), with a higher percentage of EH patients showing the CC genotype. Logistic regression showed that, for men, the CC genotype of rs1558139 was more prevalent in the EH patients than in the control subjects (p=0.026), while, for the total population, the difference disappeared (p=0.247). For men, the overall distribution of the haplotypes was significantly different between the EH patients and the control subjects (p=0.042), and the frequency of the T-T-G haplotype was also significantly lower for EH patients than for control subjects (p=0.009). In conclusion, the present results indicate that rs1558139 might be a genetic marker for EH and the T-T-G haplotype might be a protective genetic marker for EH in Japanese men.
Similar content being viewed by others
Article PDF
References
Suzuki H, Kanno Y, Efficacy of Candesartan on Outcome in Saitama Trial (E-COST) Group: Effects of candesartan on cardiovascular outcomes in Japanese hypertensive patients. Hypertens Res 2005; 28: 307–314.
Sugimoto K, Katsuya T, Ohkubo T, et al: Association between angiotensin II type 1 receptor gene polymorphism and essential hypertension: the Ohasama Study. Hypertens Res 2004; 27: 551–556.
Capdevila JH, Falck JR, Harris RC : Cytochrome P450 and arachidonic acid bioactivation: molecular and functional properties of the arachidonate monooxygenase. J Lipid Res 2000; 41: 163–181.
Bylund J, Bylund M, Oliw EH : cDNA cloning and expression of CYP4F12, a novel human cytochrome P450. Biochem Biophys Res Commun 2001; 280: 892–897.
Lasker JM, Chen WB, Wolf I, Bloswick BP, Wilson PD, Powell PK : Formation of 20-hydroxyeicosatetraenoic acid, a vasoactive and natriuretic eicosanoid, in human kidney. Role of Cyp4F2 and Cyp4A11. J Biol Chem 2000; 275: 4118–4126.
Roman RJ : P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 2002; 82: 131–185.
Kalsotra A, Cui X, Anakk S, Hinojos CA, Doris PA, Strobel HW : Renal localization, expression, and developmental regulation of P450 4F cytochromes in three substrains of spontaneously hypertensive rats. Biochem Biophys Res Commun 2005; 338: 423–431.
Gainer JV, Bellamine A, Dawson EP, et al: Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension. Circulation 2005; 111: 63–69.
Stec DE, Roman RJ, Flasch A, Rieder MJ : Functional polymorphism in human CYP4F2 decreases 20-HETE production. Physiol Genomics 2007; 30: 74–81.
Fu Z, Nakayama T, Sato N, et al: A haplotype of the CYP4A11 gene associated with essential hypertension in Japanese men. J Hypertens 2008; 26: 453–461.
Sato M, Nakayama T, Soma M, et al: Association between prostaglandin E2 receptor gene and essential hypertension. Prostaglandins Leukot Essent Fatty Acids 2007; 77: 15–20.
Morita A, Nakayama T, Doba N, Hinohara S, Soma M : Polymorphism of the C-reactive protein (CRP) gene is related to serum CRP Level and arterial pulse wave velocity in healthy elderly Japanese. Hypertens Res 2006; 29: 323–331.
Aoi N, Soma M, Nakayama T, et al: Variable number of tandem repeat of the 5′-flanking region of type-C human natriuretic peptide receptor gene influences blood pressure levels in obesity-associated hypertension. Hypertens Res 2004; 27: 711–716.
Dempster AP, Laird NM, Rubin DB : Maximum likelihood from incomplete data via the EM algorithm. J R Stat Soc Ser B 1977; 39: 1–22.
Kobayashi Y, Nakayama T, Sato N, Izumi Y, Kokubun S, Soma M : Haplotype-based case-control study revealing an association between the adrenomedullin gene and proteinuria in subjects with essential hypertension. Hypertens Res 2005; 28: 229–236.
King LM, Gainer JV, David GL, et al: Single nucleotide polymorphisms in the CYP2J2 and CYP2C8 genes and the risk of hypertension. Pharmacogenet Genomics 2005; 15: 7–13.
Yu BN, Luo CH, Wang D, et al: CYP2C9 allele variants in Chinese hypertension patients and healthy controls. Clin Chim Acta 2004; 348: 57–61.
Kivistö KT, Niemi M, Schaeffeler E, et al: CYP3A5 genotype is associated with diagnosis of hypertension in elderly patients: data from the DEBATE Study. Am J Pharmacogenomics 2005; 5: 191–195.
Iwai N, Katsuya T, Ishikawa K, et al: Human prostacyclin synthase gene and hypertension: the Suita Study. Circulation 1999; 100: 2231–2236.
Sookoian S, Gianotti TF, Gonzalez CD, Pirola CJ : Association of the C–344T aldosterone synthase gene variant with essential hypertension: a meta-analysis. J Hypertens 2007; 25: 5–13.
McGiff JC, Quilley J : 20-Hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids and blood pressure. Curr Opin Nephrol Hypertens 2001; 10: 231–237.
Jin R, Koop DR, Raucy JL, Lasker JM : Role of human CYP4F2 in hepatic catabolism of the proinflammatory agent leukotriene B4. Arch Biochem Biophys 1998; 359: 89–98.
Morris RW, Kaplan NL : On the advantage of haplotype analysis in the presence of multiple disease susceptibility alleles. Genet Epidemiol 2002; 23: 221–233.
O'Donnell CJ, Lindpaintner K, Larson MG, et al: Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation 1998; 97: 1766–1772.
Ono K, Mannami T, Iwai N : Association of a promoter variant of the haeme oxygenase-1 gene with hypertension in women. J Hypertens 2003; 21: 1497–1503.
Waxman DJ, Ram PA, Pampori NA, Shapiro BH : Growth hormone regulation of male-specific rat liver P450s 2A2 and 3A2: induction by intermittent growth hormone pulses in male but not female rats rendered growth hormone deficient by neonatal monosodium glutamate. Mol Pharmacol 1995; 48: 790–797.
Muller DN, Schmidt C, Barbosa-Sicard E, et al: Mouse Cyp4a isoforms: enzymatic properties, gender- and strainspecific expression, and role in renal 20-hydroxyeicosatetraenoic acid formation. Biochem J 2007; 403: 109–118.
Holla VR, Adas F, Imig JD, et al: Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension. Proc Natl Acad Sci U S A 2001; 98: 5211–5216.
Nakagawa K, Holla VR, Wei Y, et al: Salt-sensitive hypertension is associated with dysfunctional Cyp4a10 gene and kidney epithelial sodium channel. J Clin Invest 2006; 116: 1696–1702.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fu, Z., Nakayama, T., Sato, N. et al. Haplotype-Based Case-Control Study of the Human CYP4F2 Gene and Essential Hypertension in Japanese Subjects. Hypertens Res 31, 1719–1726 (2008). https://doi.org/10.1291/hypres.31.1719
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1291/hypres.31.1719
Keywords
This article is cited by
-
Coronary artery disease, its associations with ocular, genetic and blood lipid parameters
Eye (2024)
-
Clinically relevant pharmacogenetic markers in Tatars and Balkars
Molecular Biology Reports (2020)
-
Cytochrome P450 family 4 subfamily F member 2 (CYP4F2) rs1558139, rs2108622 polymorphisms and susceptibility to several cardiovascular and cerebrovascular diseases
BMC Cardiovascular Disorders (2018)
-
Multiplex pyrosequencing method to determine CYP2C9*3, VKORC1*2, and CYP4F2*3 polymorphisms simultaneously: its application to a Korean population and comparisons with other ethnic groups
Molecular Biology Reports (2014)
-
Association of 1347 G/A cytochrome P450 4F2 (CYP4F2) gene variant with hypertension and stroke
Molecular Biology Reports (2012)
